Turn complex safety monitoring into a competitive advantage.
Specialty therapies with strict lab requirements create operational friction that slows prescribing confidence. See how leading pharma teams have solved this at scale — with real outcomes data.
- 1.2M+ labs proactively monitored
- Improved prescriber confidence and stronger therapy adoption
- Real-time visibility into patient adherence
Trusted by leading life sciences companies
Proven at scale.
Why monitoring breaks down – and how RxPx solves it.
When monitoring fails, prescribing slows
Specialty therapies with mandatory safety testing create a coordination problem. Labs, providers, and PSPs operate in silos — creating dangerous gaps that erode prescriber confidence.
Missed labs go undetected for days or weeks
No real-time visibility into patient adherence
Care teams overwhelmed by manual follow-up
Abnormal results don’t trigger timely clinical action
Orchestrated monitoring at every touchpoint
RxPx connects the entire care ecosystem – labs, providers, patients, and PSPs – into a single coordinated safety infrastructure that removes friction without burdening care teams.
Proactive outreach before scheduled lab windows
Real-time dashboards for safety and adherence visibility
Automated detection and escalation of missed or abnormal results
Reduced admin burden — care teams focus on patients
What you’ll walk away knowing.
Infrastructure blueprint
The model RxPx uses to connect labs, providers, and PSPs – deployable across therapy areas.
Where manual workflows fail
The specific failure points in traditional monitoring that cost prescribing confidence.
Proven real-world outcomes
Adherence rates, compliance lifts, and prescriber satisfaction data from live programs.
How to apply this to your launch
A framework for evaluating where coordinated monitoring removes friction from your therapy.
A look at what you’ll discover.
The monitoring infrastructure model
How RxPx connects labs, providers, and PSPs – and why fragmented workflows fail at scale.
Operationalizing at scale
What it takes to deploy automated monitoring across thousands of patients – from enrollment to real-time oversight.
Unlock full access
to solution brief.
Ready to see
the full results?
Get the complete program data – adherence rates, compliance lifts, and prescriber confidence outcomes. Fill in your details below for instant access.
- 1.2M+ labs proactively monitored
- Improved prescriber confidence and stronger therapy adoption
- Real-time visibility into patient adherence
Why Most Therapies Fail After Approval (And No One Talks About It)
Every pharmaceutical launch is measured against ambitious commercial forecasts.
How Do We Embrace AI Without Compromising Ethics, Governance, and Trust?
How Do We Embrace AI Without Compromising Ethics, Governance, and Trust?
The Industry Shift Emerging From AXS26: From Fragmentation to Integration
At Asembia AXS26, one message surfaced repeatedly across conversations with manufacturers, specialty pharmacies, hubs, and patient support leaders: healthcare fragmentation is becoming impossible to ignore.